Kestra Private Wealth Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$801K Sell
1,512
-8
-0.5% -$3.69K 0.01% 1020
2026
Q1
$730K Sell
1,520
-3
-0.2% -$1.54K 0.01% 1004
2025
Q4
$855K Sell
1,523
-874
-36% -$496K 0.01% 877
2025
Q3
$1.23M Sell
2,397
-96
-4% -$41.9K 0.02% 692
2025
Q2
$782K Buy
2,493
+294
+13% +$88.3K 0.01% 838
2025
Q1
$670K Buy
2,199
+116
+6% +$39K 0.01% 836
2024
Q4
$692K Buy
2,083
+660
+46% +$224K 0.01% 787
2024
Q3
$485K Buy
+1,423
New +$541K 0.01% 884

Other funds holding MEDP

Kestra Private Wealth Services's MEDP Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its Medpace (MEDP) stake by 0.53% in Q2 2026, selling an estimated $3.69K and leaving 1,512 shares worth $801K. The position accounts for 0.01% of the portfolio, ranked #1020.

Kestra Private Wealth Services first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.23M in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kestra Private Wealth Services held 1,512 shares of Medpace worth $801K as of Q2 2026.
  • Kestra Private Wealth Services sold 8 Medpace shares in Q2 2026, an estimated $3.69K.
  • Medpace made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1020 holding.
  • Kestra Private Wealth Services first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • Kestra Private Wealth Services's Medpace position peaked at $1.23M in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.